Susanne Talcott

Dr. Susanne Talcott

Texas A&M University, College Station, United States

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2007 in Cancer Research
Verified
Journal Article
Open access
PDF file
Susanne TalcottSusanne Talcott
Susanne Talcott
SCSudhakar Chintharlapalli
Sudhakar Chintharlapalli
XLXiangrong Li
Xiangrong Li
SSStephen Safe
Stephen Safe
There is evidence that specificity proteins (Sp), such as Sp1, Sp3, and Sp4, are overexpressed in tumors and contribute to the proliferative and angiogenic phenotype associated with cancer cells. Sp1, Sp3, and Sp4 are expressed in a panel of estrogen receptor (ER)–positive and ER-negative breast cancer cell lines, and we hypothesized that regulation of their expression may be due to microRNA-27a (miR-27a), which is also expressed in these cell lines and has been reported to regulate the zinc finger ZBTB10 gene, a putative Sp repressor. Transfection of ER-negative MDA-MB-231 breast cancer cells with antisense miR-27a (as-miR-27a) resulted in increased expression of ZBTB10 mRNA and decreased expression of Sp1, Sp3, and Sp4 at the mRNA and protein levels and also decreased activity in cells transfected with constructs containing Sp1 and Sp3 promoter inserts. In addition, these responses were accompanied by decreased expression of Sp-dependent survival and angiogenic genes, including survivin, vascular endothelial growth factor (VEGF), and VEGF receptor 1 (VEGFR1). Moreover, similar results were observed in MDA-MB-231 cells transfected with ZBTB10 expression plasmid. Both as-miR-27a and ZBTB10 overexpression decreased the percentage of MDA-MB-231 cells in S phase of the cell cycle; however, ZBTB10 increased the percentage of cells in G0-G1, whereas as-miR-27a increased the percentage in G2-M. This latter response was associated with induction of Myt-1 (another miR-27a target gene), which inhibits G2-M through enhanced phosphorylation and inactivation of cdc2. Thus, the oncogenic activity of miR-27a in MDA-MB-231 cells is due, in part, to suppression of ZBTB10 and Myt-1. [Cancer Res 2007;67(22):11001–11]

13 October 2006 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
Susanne TalcottSusanne Talcott
Susanne Talcott
PJPetra Jilma-Stohlawetz
Petra Jilma-Stohlawetz
JRJolian Rios
Jolian Rios
LHLal Hingorani
Lal Hingorani
HDHartmut Derendorf
Hartmut Derendorf


1 June 2008 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
LPLisbeth A. Pacheco-Palencia
Lisbeth A. Pacheco-Palencia
Susanne TalcottSusanne Talcott
Susanne Talcott
STStephen T. Talcott
Stephen T. Talcott

12 August 2008 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
Susanne TalcottSusanne Talcott
Susanne Talcott
JRJolian Rios
Jolian Rios
PJPetra Jilma-Stohlawetz
Petra Jilma-Stohlawetz
LPLisbeth A. Pacheco-Palencia
Lisbeth A. Pacheco-Palencia
BMBernd Meibohm
Bernd Meibohm
HDHartmut Derendorf
Hartmut Derendorf

1 August 2003 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
Susanne TalcottSusanne Talcott
Susanne Talcott
STStephen T. Talcott
Stephen T. Talcott
Susan PercivalSusan Percival
Susan Percival
Little information is available regarding possible synergistic or antagonistic biochemical interactions among polyphenols contained in fruits and vegetables. Identifying potential interactions among these compounds may help to define the efficiency of polyphenol-containing foods in cancer prevention as related to structure-function activity of the compounds. The objective of this study was to investigate interactions between quercetin and ellagic acid, two polyphenolics that are present predominantly in small fruits, on cell death and proliferation-related variables in the MOLT-4 human leukemia cell line. Assays were performed to determine cell cycle kinetics, proliferation, apoptotic DNA-fragmentation and caspase-3-activity after 12, 24 and 48 h. Ellagic acid significantly potentiated the effects of quercetin (at 5 and 10 μmol/L each) in the reduction of proliferation and viability and the induction of apoptosis. Significant alterations in cell cycle kinetics were also observed. The synergy was confirmed by an isobolographic analysis of the cell proliferation data. The interaction of ellagic acid and quercetin demonstrated an enhanced anticarcinogenic potential of polyphenol combinations, which was not based solely on the additive effect of individual compounds, but rather on synergistic biochemical interactions.